180 related articles for article (PubMed ID: 35152168)
41. Seroprevalence of Toxoplasma gondii infection in blood donors in mainland China: a systematic review and meta-analysis.
Wang T; Han Y; Pan Z; Wang H; Yuan M; Lin H
Parasite; 2018; 25():36. PubMed ID: 30040610
[TBL] [Abstract][Full Text] [Related]
42. Prevalence of Toxoplasma gondii infection in animals of the Arabian Peninsula between 2000-2020: A systematic review and meta-analysis.
Abdelgadier A; Assaad N; Elhussein Z; Al-Marri AM; Suliman S; Eltom K; Al-Mslemani EA; Al-Zeyara AA; Hussein ARME; Enan KA
Vet Med Sci; 2023 Jan; 9(1):471-480. PubMed ID: 36408778
[TBL] [Abstract][Full Text] [Related]
43. Toxoplasma gondii infection in cancer patients: prevalence, risk factors, genotypes and association with clinical diagnosis.
Cong W; Liu GH; Meng QF; Dong W; Qin SY; Zhang FK; Zhang XY; Wang XY; Qian AD; Zhu XQ
Cancer Lett; 2015 Apr; 359(2):307-13. PubMed ID: 25641340
[TBL] [Abstract][Full Text] [Related]
44. The global seroprevalence of Toxoplasma gondii among wild boars: A systematic review and meta-analysis.
Rostami A; Riahi SM; Fakhri Y; Saber V; Hanifehpour H; Valizadeh S; Gholizadeh M; Pouya RH; Gamble HR
Vet Parasitol; 2017 Sep; 244():12-20. PubMed ID: 28917302
[TBL] [Abstract][Full Text] [Related]
45. Association of Toxoplasma gondii Seropositivity With Cognitive Function in Healthy People: A Systematic Review and Meta-analysis.
de Haan L; Sutterland AL; Schotborgh JV; Schirmbeck F; de Haan L
JAMA Psychiatry; 2021 Oct; 78(10):1103-1112. PubMed ID: 34259822
[TBL] [Abstract][Full Text] [Related]
46. Association of Toxoplasma gondii infection with cardiovascular diseases: a cross-sectional study among patients with heart failure diseases in Urmia, North-West of Iran.
Khademvatan S; Khademvatani K; Tappeh KH; Asadi N; Khezri P; Abasi E
Ann Parasitol; 2020; 66(2):193-199. PubMed ID: 32592458
[TBL] [Abstract][Full Text] [Related]
47. Prevalence of Toxoplasma gondii infection in chickens in China during 1993-2021: a systematic review and meta-analysis.
Nie LB; Gong QL; Wang Q; Zhang R; Shi JF; Yang Y; Li JM; Zhu XQ; Shi K; Du R
Parasitol Res; 2022 Jan; 121(1):287-301. PubMed ID: 34993635
[TBL] [Abstract][Full Text] [Related]
48. The global seroprevalence of
Shariatzadeh SA; Sarvi S; Hosseini SA; Sharif M; Gholami S; Pagheh AS; Montazeri F; Nayeri T; Nakhaei M; Mikaeili Galeh T; Daryani A
Parasitology; 2021 Oct; 148(12):1417-1433. PubMed ID: 34187606
[TBL] [Abstract][Full Text] [Related]
49. Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis.
Daryani A; Sarvi S; Aarabi M; Mizani A; Ahmadpour E; Shokri A; Rahimi MT; Sharif M
Acta Trop; 2014 Sep; 137():185-94. PubMed ID: 24887263
[TBL] [Abstract][Full Text] [Related]
50. Meta-analysis of Toxoplasma gondii in pigs intended for human consumption in Mainland China.
Zhang XX; Ren WX; Tan QD; Hou G; Fei YC; Zhao LJ; Zhao Q; Sun D
Acta Trop; 2019 Oct; 198():105081. PubMed ID: 31299285
[TBL] [Abstract][Full Text] [Related]
51. Global prevalence and risk factors associated with Toxoplasma gondii infection in wild birds: A systematic review and meta-analysis.
Chen C; Qin SY; Yang X; Li XM; Cai Y; Lei CC; Zhao Q; Elsheikha HM; Cao H
Prev Vet Med; 2024 May; 226():106187. PubMed ID: 38554654
[TBL] [Abstract][Full Text] [Related]
52. The prevalence and genotypic analysis of Toxoplasma gondii from individuals in Scotland, 2006-2012.
Burrells A; Opsteegh M; Pollock KG; Alexander CL; Chatterton J; Evans R; Walker R; McKenzie CA; Hill D; Innes EA; Katzer F
Parasit Vectors; 2016 Jun; 9(1):324. PubMed ID: 27267112
[TBL] [Abstract][Full Text] [Related]
53. Seroepidemiology of Toxoplasma gondii infection in psychiatric inpatients in a northern Mexican city.
Alvarado-Esquivel C; Alanis-Quiñones OP; Arreola-Valenzuela MA; Rodríguez-Briones A; Piedra-Nevarez LJ; Duran-Morales E; Estrada-Martínez S; Martínez-García SA; Liesenfeld O
BMC Infect Dis; 2006 Dec; 6():178. PubMed ID: 17178002
[TBL] [Abstract][Full Text] [Related]
54. Association between
Catchpole A; Zabriskie BN; Bassett P; Embley B; White D; Gale SD; Hedges D
Int J Environ Res Public Health; 2023 Mar; 20(5):. PubMed ID: 36901457
[TBL] [Abstract][Full Text] [Related]
55. Exposure to
Ducrocq J; Simon A; Lemire M; De Serres G; Lévesque B
Vector Borne Zoonotic Dis; 2021 Jan; 21(1):40-49. PubMed ID: 33202167
[No Abstract] [Full Text] [Related]
56. Toxoplasma gondii infection in Kyrgyzstan: seroprevalence, risk factor analysis, and estimate of congenital and AIDS-related toxoplasmosis.
Minbaeva G; Schweiger A; Bodosheva A; Kuttubaev O; Hehl AB; Tanner I; Ziadinov I; Torgerson PR; Deplazes P
PLoS Negl Trop Dis; 2013; 7(2):e2043. PubMed ID: 23409201
[TBL] [Abstract][Full Text] [Related]
57. Risk factors associated with seropositivity for Toxoplasma gondii in population-based studies among immunocompromised patients (pregnant women, HIV patients and children) in West African countries, Cameroon and Gabon: a meta-analysis.
Odeniran PO; Omolabi KF; Ademola IO
Acta Trop; 2020 Sep; 209():105544. PubMed ID: 32461111
[TBL] [Abstract][Full Text] [Related]
58. Seroprevalence of Toxoplasma gondii infection in arthritis patients in eastern China.
Tian AL; Gu YL; Zhou N; Cong W; Li GX; Elsheikha HM; Zhu XQ
Infect Dis Poverty; 2017 Oct; 6(1):153. PubMed ID: 29065914
[TBL] [Abstract][Full Text] [Related]
59. Serological evidence of Toxoplasma gondii infection as potential risk for the development of lepromatous leprosy in an endemic area for both neglected tropical diseases in Brazil.
Oliveira LRP; Martins LM; Souza RDC; Scheidegger de Castro Y; Nascimento LS; da Silva JA; Nahn Junior EP; da Silva WD; Peixoto-Rangel AL
Infect Dis Poverty; 2020 Feb; 9(1):19. PubMed ID: 32051036
[TBL] [Abstract][Full Text] [Related]
60. Global seroprevalence of
Bisetegn H; Debash H; Ebrahim H; Mahmood N; Gedefie A; Tilahun M; Alemayehu E; Mohammed O; Feleke DG
Health Sci Rep; 2023 Jun; 6(6):e1319. PubMed ID: 37287705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
